Additional effect of statin to PegIFN/Ribavirin treatment in chronic hepatitis C patients

Not Applicable

• Conditions: Hepatitis C of genotype1 in high viral load(> =5logIU/mL Taqman) and Hypercholesteremia

• Registration Number: JPRN-UMIN000003468
• Lead Sponsor: Showa University School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-04-09
• Study Completion: 2012-07-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Not provided

Exclusion Criteria

1) Used Ribavirin in previous treatments 2) Pregnant , possibly pregnant or lactating women 3) Patients with severe heart disease 4) Chronic kidney failure or creatinine clearance of <=50 mL/min 5) Current or history of severe psychiatric disorder 6) Autoimmune hepatitis 7) Intolerance to statin

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
SVR rate